CESC is a vertically integrated power utility that generates and distributes electricity to millions of customers in Kolkata and several other Indian cities through long-term licenses and franchises.
The company possesses a wide moat rooted in exclusive regulatory licenses and high switching costs for its distribution areas. This is corroborated by stable net margins and a cash conversion ratio significantly above 1.0, indicating that its monopolistic position translates into reliable cash flow despite heavy regulation.
Management is aggressively pivoting toward renewable energy with a 10 GW target by 2032, while maintaining a consistent dividend policy. While thermal assets remain the cash cow, the high debt-to-equity ratio reflects the capital-intensive nature of building out this new green capacity.
The collapse was driven by a lethal combination of regulatory tightening and a failed green energy pivot. The company's aggressive 10 GW renewable target required massive debt financing that its 2.5x interest coverage could not sustain when interest rates rose. Simultaneously, regulators cracked down on the accrual of regulatory income, forcing massive non-cash write-downs that decimated the balance sheet. As the thermal cash cows faced accelerated decommissioning mandates, the company was left with stranded assets, a mountain of debt, and a dividend that had to be eliminated to prevent insolvency.
RichFakir rates CESC Ltd's business quality as mediocre — 48/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as wide.
On our model, CESC Ltd is trading about 1% above our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on CESC Ltd is: Not rated. A mediocre business at a fair price — it does not make our shortlist right now.
RichFakir's educational estimate of CESC Ltd's fair value is about ₹117 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →